Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2423 participants.
Also called NCT06773364
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,423 participants
- Sponsor
- Registry
-
NCT06773364
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06773364. Randomized; single masking; primary purpose treatment. Start 2025-04-30 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
- Acronym
- EAST
- Condition
- Suspected Stroke
- Intervention (Drug)
- Levetiracetam
- Intervention (Other)
- Guide-recommended management
- Intervention (Other)
- The lying flat (0°) head position
- Intervention (Other)
- The sitting-up (≥30°) head position
- Lead sponsor
- Shanghai East Hospital
Record details
- Record id
cardio:ct-nct06773364- Content hash
408990dd8eade53ecd0e08c09e291fabaaedc1ed7e449d42962e5f388e75fbec